SYMBIOTEC — Symbiotec Pharmalab Share News
0.000.00%
Last trade - 00:00- IN₹74.81bn
- IN₹78.41bn
- IN₹17.38bn
Brief: Symbiotec Pharmalab Unit Enters Into Strategic Commercialization Agreement
Brief: Symbiotec Pharmalab Receives U.S. FDA Eir For Pithampur Facility With Vai Status
India's Symbiotec Pharmalab declines after Q1 profit fall
India's Symbiotec Pharmalab rises after muted debut, valued at $779 million